|
|
|
Codexis inc (NASDAQ: CDXS) |
|
Codexis inc
Officers & Directors
Executives and Directors of Codexis Inc: - Stephen Dilly President and Chief Executive Officer (Principal Executive Officer) - Sriram Ryali Chief Financial Officer (Principal Financial and Accounting Officer) - Byron L. Dorgan Chairman of the Board of Directors - Alison Moore Director - H. Stewart Parker Director - Dennis P. Wolf Director - Esther Martinborough Director - David V. Smith Director - Rahul Singhvi Director - Jennifer Aaker Director ,
Codexis inc currently has 146 employees.
News about Codexis inc Key Personnel |
Codexis: Cultivating Talent Through Strategic Equity Inducement in the Biotechnology SectorIn a landscape dominated by rapid advancements and intense competition, biotechnology companies are increasingly turning to innovative strategies for attracting and retaining top talent. Codexis, Inc. (NASDAQ: CDXS), a prominent player in the realm of enzymatic solutions for the manufacturing of therapeutics, stands at the forefront of this trend. With a solidified commitment to growth and innovation, Codexis recently announced a series of progressive equity inducement grants aimed at bolstering its talent acquisition efforts as it charts its course through an evolving market.In a noteworthy move earlier this year, on ...
|
Codexis Strengthens Talent Acquisition Strategy with Strategic Equity Inducement Grants Amidst Continued GrowthIn a strategic bid to enhance its talent acquisition efforts and solidify its position in the competitive biotechnology sector, Codexis, Inc. (NASDAQ: CDXS), a frontrunner in enzymatic solutions for efficient therapeutics manufacturing, recently announced significant equity inducement grants. This initiative, embodying the firm’s commitment to attracting and retaining top-tier talent, is integral as Codexis navigates its path forward with ambitious growth plans.On January 10, 2025, Codexis revealed that its Compensation Committee had approved equity grants for two newly hired employees as part of...
|
Unlocking Growth: Codexis Enhances Financial Resilience and Human Capital Amid Market ChallengesIn an era marked by uncertainty in the biotech sector, Codexis Inc. a prominent enzyme engineering company based in Redwood City, California, is taking strategic steps to bolster its financial health and enhance its talent pool. Recently, the company announced a significant capital injection of $31 million through an at-the-market (ATM) offering, extending its cash runway into 2027. Coupled with its commitment to attract top talent via innovative employment inducement grants, Codexis appears poised to navigate these turbulent waters and maintain its trajectory of growth. Financial Fortification Through Capital Rai...
|
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.
